At the European Association for the Study of Diabetes conference in Milan, Italy, clinicians and scientists shaping the future of cardiometabolic health will come together, and our research will be part of that conversation. Ruth Gimeno, our Group Vice President of Diabetes and Metabolic Research, previews new findings on an investigational dual mechanism treatment for obesity and type 2 diabetes — our first look at how the two mechanisms perform together. #EASD2026